Barrett Katz, MD, MBA, serves as Chief Medical Officer of GenSight Biologics, a Paris based biotech company devoted to the discovery and development of genetic therapies for Ophthalmic indications. He is an internationally recognized Neuro-Ophthalmologist who previously served at the Montefiore Medical Center and Albert Einstein College of Medicine as Professor of Ophthalmology, Neurology and Neurosurgery, and held the Frances DeJur Chair in Ophthalmology. He also was the Executive Director of the Office of Clinical Trials, which managed all clinical trials across all areas at both the hospital and medical school.
He has been actively engaged in the private biotech arena and drug development industry for the past several years. He served as Chief Executive Officer of Danube Pharmaceuticals and Chief Medical Officer of both Fovea Pharmaceuticals in Paris, and previous to that, at Eyetech Inc., in NYC. Eyetech brought the first medical therapy of macular degeneration to market. Prior to that, he had a distinguished career in academia, recently as Professor and Chairman of the Department of Ophthalmology at the George Washington University School of Medicine. Over the course of his 25-year career, He has earned a reputation as a gifted clinician and teacher as well as an accomplished researcher. An active clinical trialist himself, he has also had hands-on experience at the Food & Drug Administration in Rockville, Maryland and established a fellowship there for Drug Development in Ophthalmology.
He had received his medical degree from Case-Western Reserve University School of Medicine after graduating from Colgate University. He interned in Internal Medicine at Parkland Hospital in Dallas, went to the National Institutes of Health in Neuro-Virology, completed a Neurology residency at Harvard Medical School and an Ophthalmology residency at Tufts-New England Medical Center. He served additional fellowships at Harvard, the National Hospital for Nervous Disease at Queen’s Square in London and at the University of California–San Francisco (UCSF). He obtained an MBA in finance and health care management from the University of Rochester’s Simon School of Business, and served on the faculties of the University of California–San Diego, UCSF, and the University of Rochester. He is also CEO and Chairman of the Board of both he World Eye Missions and the Center for Ophthalmology Research and Education, two non-profits devoted to Ophthalmology needs.